None

It seems Nvidia ( NVDA 1.18% ) is a victim of its own success. After another incredible quarter in which it doubled its earnings per share (EPS) year over year, the chipmaker's stock sank in the days following its Q3 numbers release. The fact is, expectations could hardly be higher. It's a good thing the company appears to be still firing on all cylinders. This isn't the first time it's been in this situation, and it's likely not the last. Nvidia saw its stock retreat nearly 20% in the weeks following its last release, only to gain nearly 35% from that low. There is good reason to remain optimistic, as the next year is full of major catalysts for the company. On Tuesday, Dec. 3, Nvidia joined other leading Artificial Intelligence (AI) firms to discuss the future of the industry with the investment community. The annual UBS Global Technology and AI Conference presents a chance for Nvidia to show continued leadership and make the case for why it has so much further to go. The event marries the technical with the practical, shedding light on just how impactful AI can be in creating real-world value. While one event is unlikely to move the needle, every chance the company -- and the industry, for that matter -- has a chance to make its case count. Here are three reasons why Nvidia is a buy as the event gets underway. 1. Nvidia's hardware continues to dominate Look, this is hardly news, but it bears repeating: the AI market is huge, growing rapidly, and there's ample reason to believe this will continue. PwC -- one of the "big four" accounting firms -- believes AI can add $15.7 trillion to the global economy by 2030. Statista predicts a compound annual growth rate (CAGR) for the total AI market of 28.3% through 2030. It's not just the analysts and talking heads that think so; CEOs from around Silicon Valley reiterated their commitment to AI and, more to the point, to spending billions of dollars on AI infrastructure. In Meta 's last earnings call , CEO Mark Zuckerberg stated that despite record capital expenditures , his company "should invest more" because AI will "accelerate [Meta's] core business" and "should have strong ROI over the next few years. That is great news for Nvidia. The company's chips supply the vast majority of the industry, and this market dominance is expected to continue in the foreseeable future. At this point, not even AMD can offer a chip that matches the performance of Nvidia's flagship chips. While this lead will likely shrink as time passes, it's doubtful Nvidia's would be leapfrogged. Nvidia has enormous resources -- in capital and talent -- it can use to defend its pole position. 2. Blackwell is here Blackwell, Nvidia's newest line of Superchips, releases this month, and samples are already in the hands of many of its major clients. The chips are incredibly powerful, more than twice as powerful as its current Hopper chips, and demand for them is at a fever pitch. CEO Jensen Huang described the demand as "staggering" and reports have indicated the company has been sold out of them for a full year. This is a big moment for Nvidia, and Wall Street is keen to see the company deliver a successful launch. If there are hiccups expected, Nvidia's executive team certainly didn't share them in its Q3 earnings call. The team painted a rosy picture of the next year and Blackwell's roll-out, expecting more Blackwells to ship than previously expected. I think there is a good chance that revenue from Blackwell will be even larger than Wall Street expects, but we will learn much more in the coming months. 3. Agentic AI is the next big thing The term has been thrown around a lot recently, but a big focus of Nvidia's call, apart from the launch of Blackwell, was the development and adoption of agentic AI -- essentially AI that can actually do , not just create. Jensen Huang likes to think of them as "AI coworkers" that can "assist employees in performing their jobs faster and better." I think that agentic AI if done well, is where the real value of AI lies. This is where true efficiencies can be made throughout organizations of all types. One of the ongoing questions in the market as a whole is whether AI can deliver value that justifies the enormous costs involved. If it can, this is where we will see it. Nvidia is ahead of this trend, offering "an operating platform of agentic AI," as Huang puts it, insisting that industry leaders are already using it to build "copilots" -- an industry term for AI helpers and agents.

None

By Llazar Semini TIRANA, Albania — Albanian opposition lawmakers and their supporters blocked the capital’s main streets for hours Tuesday accusing the government of corruption and demanding it be replaced by a technocratic caretaker Cabinet until 2025 parliamentary elections. Hundreds of activists blocked traffic at Tirana’s main intersections accusing the Socialist Party of Prime Minister Edi Rama of corruption, manipulating earlier elections and usurping the powers of the judiciary. Led by lawmakers, opposition supporters — some coming from other cities — were involved in sporadic clashes with anti-riot police trying to clear the streets. Others sat down in the street or tried to push police officers away. “Rama go away,” was a call repeated by protesters in many places. Riot police wear their gas masks during a protest, in Tirana, Albania, Tuesday, Nov. 26, 2024 over the arrests of their leader Sali Berisha and former President Ilir Meta in separate corruption cases, saying the charges are politically motivated. (AP Photo/Vlasov Sulaj) Police use water canons against opposition supporters in Tirana, Albania, Tuesday, Nov. 26, 2024 during an anti-government protest over the arrests of their leader Sali Berisha and former President Ilir Meta in separate corruption cases, saying the charges are politically motivated. (AP Photo/Vlasov Sulaj) Supporters of the Albanian opposition clash with riot police in Tirana, Albania , Tuesday, Nov. 26, 2024 during an anti-government protest over the arrests of their leader Sali Berisha and former President Ilir Meta in separate corruption cases, saying the charges are politically motivated. (AP Photo/Vlasov Sulaj) Supporters of the Albanian opposition take part in an anti-government protest in Tirana, Albania, Tuesday, Nov. 26, 2024 over the arrests of their leader Sali Berisha and former President Ilir Meta in separate corruption cases, saying the charges are politically motivated. (AP Photo/Vlasov Sulaj) Riot police stand guard a street in central Tirana, Albania, Tuesday, Nov. 26, 2024 during an anti-government protest over the arrests of their leader Sali Berisha and former President Ilir Meta in separate corruption cases, saying the charges are politically motivated. (AP Photo/Vlasov Sulaj) Police officers help a woman after a clash between riot police and opposition supporters in Tirana, Albania, Tuesday, Nov. 26, 2024 during an anti-government protest over the arrests of their leader Sali Berisha and former President Ilir Meta in separate corruption cases, saying the charges are politically motivated. (AP Photo/Vlasov Sulaj) Police use water canons against opposition supporters in Tirana, Albania, Tuesday, Nov. 26, 2024 during an anti-government protest over the arrests of their leader Sali Berisha and former President Ilir Meta in separate corruption cases, saying the charges are politically motivated. (AP Photo/Vlasov Sulaj) An elderly woman is being cared after clashes between riot police and opposition supporters in Tirana, Albania, Tuesday, Nov. 26, 2024 during an anti-government protest over the arrests of their leader Sali Berisha and former President Ilir Meta in separate corruption cases, saying the charges are politically motivated. (AP Photo/Vlasov Sulaj) Police use water canons against opposition supporters in Tirana, Albania , Tuesday, Nov. 26, 2024 during an anti-government protest over the arrests of their leader Sali Berisha and former President Ilir Meta in separate corruption cases, saying the charges are politically motivated. (AP Photo/Vlasov Sulaj) Riot police wear their gas masks during a protest, in Tirana, Albania, Tuesday, Nov. 26, 2024 over the arrests of their leader Sali Berisha and former President Ilir Meta in separate corruption cases, saying the charges are politically motivated. (AP Photo/Vlasov Sulaj) Hundreds of police officers were deployed to protect government buildings and keep streets clear for traffic and preserve order. They used water guns mounted on trucks to keep protesters away from City Hall and Wilson Square, and tear gas in at least in one case. The conservative Democratic Party and its supporters in an opposition coalition also have been holding protests over the arrests of their leader Sali Berisha and former President Ilir Meta in separate corruption cases , saying the charges are politically motivated. “The Albanians’ revolt and civil disobedience cannot be stopped,” said the Democrats’ Secretary-General Flamur Noka, the most senior leader while Berisha is under house arrest. As Noka was addressing journalists, he stopped speaking out of respect when a prayer was heard from the new Muslim mosque nearby. Albania’s 2.4 million population is more than half Muslim. They live peacefully alongside Catholic and Orthodox Christians and other smaller religious communities. The protest ended after three hours with the opposition leaders pledging to continue with rallies all around the country. Albania holds parliamentary elections next spring, which Rama’s Socialists are poised to win, according to polls, partly because the opposition is divided. The United States and the European Union have urged the opposition to resume dialogue with the government, saying violence won’t help the country integrate into the 27-nation European Union. In October, Tirana started discussions with the bloc on how the country aligns with EU stances on the rule of law, the functioning of democratic institutions and the fight against corruption. Albania aims to join the bloc by 2030, according to Rama.

Column: Chicago Bulls are still looking for an identity while former Bull Alex Caruso gets rewarded for hisFox News Flash top sports headlines are here. Check out what's clicking on Foxnews.com. The National Lacrosse League has launched an investigation after a jarring scene broke out following a recent Halifax Thunderbirds game. A video circulated online showing professional lacrosse player Tyson Bell engaged in a physical altercation with fans following Saturday's game against the Colorado Mammoth . At one point during the fight, Bell appeared to utilize his lacrosse stick. The NLL acknowledged it was aware of what transpired after this past weekend's game. CLICK HERE FOR MORE SPORTS COVERAGE ON FOXNEWS.COM Lacrosse sticks lay on the field before a game. (Grant Halverson/NCAA Photos via Getty Images) "The National Lacrosse League is aware of an alleged incident between a player and spectator(s) following the Halifax at the Colorado game on December 21st," the NLL said in a statement released on Dec. 22. "The League will provide an update after it has completed its investigation." The video shared to social media appeared to show Bell "attacking the fans with his fist before swinging his stick at them," per TMZ Sports . MICHIGAN'S SHOCKING UPSET OVER OHIO STATE ERUPTS INTO CHAOS AS MASSIVE BRAWL BREAKS OUT AT MIDFIELD Fans did appear to direct insults at the athletes as they made their way to the locker room. Bell's teammates eventually intervened and held him back in an attempt to deescalate the situation. A broken lacrosse stick lies on the sideline. (Erica Denhoff/Icon Sportswire via Getty Images) Colorado defeated Halifax on Saturday. Colorado forward Will Malcolm led the team with 10 points and seven goals in the 9-14 victory. Meanwhile, Bell did not record a goal during the game. CLICK HERE TO GET THE FOX NEWS APP Other details surrounding the incident were not immediately known. The Thunderbirds host the Albany FireWolves on Dec. 28 at Scotiabank Centre. Follow Fox News Digital’s sports coverage on X , and subscribe to the Fox News Sports Huddle newsletter . Chantz Martin is a sports writer for Fox News Digital.

News digest: Primitive premier blows up at mediaCIBC Asset Management Inc bought a new position in shares of Taylor Morrison Home Co. ( NYSE:TMHC – Free Report ) during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund bought 3,129 shares of the construction company’s stock, valued at approximately $220,000. A number of other institutional investors have also recently modified their holdings of the business. Principal Financial Group Inc. grew its stake in shares of Taylor Morrison Home by 3.5% during the 3rd quarter. Principal Financial Group Inc. now owns 2,051,580 shares of the construction company’s stock worth $144,144,000 after purchasing an additional 69,222 shares during the period. Bank of New York Mellon Corp grew its position in Taylor Morrison Home by 0.4% during the second quarter. Bank of New York Mellon Corp now owns 1,066,470 shares of the construction company’s stock worth $59,125,000 after buying an additional 4,638 shares during the period. Assenagon Asset Management S.A. increased its holdings in Taylor Morrison Home by 271.0% in the third quarter. Assenagon Asset Management S.A. now owns 896,032 shares of the construction company’s stock valued at $62,955,000 after buying an additional 654,541 shares in the last quarter. Allspring Global Investments Holdings LLC increased its holdings in Taylor Morrison Home by 7.6% in the third quarter. Allspring Global Investments Holdings LLC now owns 846,270 shares of the construction company’s stock valued at $59,459,000 after buying an additional 60,021 shares in the last quarter. Finally, Wedge Capital Management L L P NC lifted its position in shares of Taylor Morrison Home by 1.5% during the 3rd quarter. Wedge Capital Management L L P NC now owns 738,830 shares of the construction company’s stock valued at $51,910,000 after acquiring an additional 10,911 shares during the period. 95.16% of the stock is currently owned by hedge funds and other institutional investors. Taylor Morrison Home Stock Up 2.3 % Shares of NYSE:TMHC opened at $71.07 on Friday. The company has a current ratio of 6.24, a quick ratio of 0.69 and a debt-to-equity ratio of 0.37. The firm has a market cap of $7.35 billion, a price-to-earnings ratio of 9.19 and a beta of 1.96. The stock’s 50-day moving average price is $69.40 and its two-hundred day moving average price is $63.50. Taylor Morrison Home Co. has a 12-month low of $44.32 and a 12-month high of $74.69. Analysts Set New Price Targets Several equities analysts recently weighed in on TMHC shares. Wedbush raised Taylor Morrison Home from a “neutral” rating to an “outperform” rating and raised their price objective for the company from $65.00 to $85.00 in a research note on Friday, October 25th. BTIG Research increased their target price on Taylor Morrison Home from $78.00 to $86.00 and gave the company a “buy” rating in a report on Thursday, October 24th. StockNews.com raised Taylor Morrison Home from a “hold” rating to a “buy” rating in a report on Thursday, October 24th. Royal Bank of Canada increased their price objective on Taylor Morrison Home from $74.00 to $77.00 and gave the company an “outperform” rating in a research note on Thursday, October 24th. Finally, Barclays boosted their target price on shares of Taylor Morrison Home from $72.00 to $75.00 and gave the company an “equal weight” rating in a research note on Thursday, October 24th. Two research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, Taylor Morrison Home has an average rating of “Moderate Buy” and an average price target of $77.33. Read Our Latest Stock Analysis on Taylor Morrison Home Insider Activity In related news, EVP Darrell Sherman sold 26,757 shares of the firm’s stock in a transaction that occurred on Monday, October 28th. The shares were sold at an average price of $70.00, for a total value of $1,872,990.00. Following the transaction, the executive vice president now owns 109,217 shares in the company, valued at approximately $7,645,190. This trade represents a 19.68 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website . Also, Director William H. Lyon sold 9,075 shares of the business’s stock in a transaction that occurred on Thursday, November 7th. The stock was sold at an average price of $72.08, for a total transaction of $654,126.00. Following the sale, the director now owns 2,136,241 shares of the company’s stock, valued at approximately $153,980,251.28. This represents a 0.42 % decrease in their ownership of the stock. The disclosure for this sale can be found here . Insiders sold 104,337 shares of company stock valued at $7,356,683 in the last ninety days. Company insiders own 3.50% of the company’s stock. Taylor Morrison Home Company Profile ( Free Report ) Taylor Morrison Home Corporation, together with its subsidiaries, operates as a public homebuilder in the United States. The company designs, builds, and sells single and multi-family detached and attached homes; and develops lifestyle and master-planned communities. It develops and constructs multi-use properties consisting of commercial space, retail, and multi-family properties under the Urban Form brand name. Further Reading Want to see what other hedge funds are holding TMHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Taylor Morrison Home Co. ( NYSE:TMHC – Free Report ). Receive News & Ratings for Taylor Morrison Home Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Taylor Morrison Home and related companies with MarketBeat.com's FREE daily email newsletter .

Syracuse, Albany each hoping to get right at expense of the other

Nerve cells of blind mice retain their visual functionPsoriatic Arthritis Treatment: A New Era of Relief 11-23-2024 11:38 AM CET | Advertising, Media Consulting, Marketing Research Press release from: The Business Research Company The Business Research Company recently released a comprehensive report on the Global Psoriatic Arthritis Treatment Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The psoriatic arthritis treatment market size has grown strongly in recent years. It will grow from $10.93 billion in 2023 to $12 billion in 2024 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to increased diagnosis, rising prevalence of psoriatic arthritis, increasing awareness of psoriatic arthritis and its treatments, expanding range of approved psoriatic arthritis treatments, government support for research and development, increased investment from pharmaceutical companies. The psoriatic arthritis treatment market size is expected to see strongly grown in the next few years. It will grow to $17.16 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to personalized medicine, emerging biologics and small molecules, expanding treatment options, global aging population. Major trends in the forecast period include advancements in biologics, oral small molecules, targeting specific pathways, telemedicine and remote monitoring, patient-centered care, real-world evidence. Get The Complete Scope Of The Report @ https://www.thebusinessresearchcompany.com/report/psoriatic-arthritis-treatments-global-market-report Market Drivers and Trends: The rise in the prevalence of psoriasis and psoriatic arthritis boosted the growth of the psoriatic arthritis treatment market. Psoriasis (PSO) and psoriatic arthritis (PsA) are inflammatory disorders that can severely impair health and quality of life. Psoriasis is associated with inflammatory arthritis, known as psoriatic arthritis (PsA), with an incidence of 30% in psoriatic patients. For instance, in June 2021, according to the National Psoriasis Foundation, a US-based healthcare agency, more than 8 million people in the United States and 125 million people worldwide suffered from psoriasis, a chronic immune-mediated illness. Furthermore, in the USA, about 30% of people with psoriasis also develop psoriatic arthritis. Thus, an increase in the prevalence of psoriasis and psoriatic arthritis drives market growth. The development of novel drugs such as Janus kinase (JAK) inhibitors for treating psoriatic arthritis is shaping the market. Janus kinase (JAK) inhibitors are orally administered small molecules that are emerging as a novel treatment for psoriatic arthritis patients. There are three JAK inhibitors approved for the treatment of autoimmune diseases: tofacitinib, baricitinib, and upadacitinib. Among them, Xeljanz (tofacitinib) and Xeljanz (tofacitinib) XR are the first Janus kinase (JAK) inhibitors that have been approved by the Food and Drug Administration (FDA) and the European Medicines Agency (EMA). They are used to treat adult patients with active psoriatic arthritis (PsA), who have had an inadequate response or intolerance to methotrexate or other disease-modifying antirheumatic drugs (DMARDs). In June 2020, AbbVie, a leading US-based pharmaceutical company, announced that it had applied for the approval of upadacitinib (RINVOQ), a JAK inhibitor, with the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Key Benefits for Stakeholders: • Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry. • Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning. • Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition. • Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights. • Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale. Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=3458&type=smp Major Key Players of the Market: AbbVie Inc.; Amgen Astellas BioPharma K.K.; Johnson & Johnson Services Inc.; Bristol-Myers Squibb Company; Celgene Corporation; Novartis International AG; Eli Lilly and Company; Pfizer Inc.; CB Biosciences Inc.; Hoffmann-La Roche Ltd.; Merck & Co. Inc.; AstraZeneca plc; Sanofi SA; Otsuka Pharmaceutical Co. Ltd.; Sumitomo Dainippon Pharma Co. Ltd.; Bayer AG; Abbott Laboratories; Eisai Inc.; Janssen Pharmaceuticals Inc.; Bausch Health Companies Inc.; F. Hoffmann-La Roche Ltd.; Gilead Sciences Inc.; GlaxoSmithKline plc; LEO Pharma A/S; Regeneron Pharmaceuticals Inc.; Sun Pharmaceutical Industries Ltd.; Takeda Pharmaceutical Company Limited; Teva Pharmaceutical Industries Ltd.; Valeant Pharmaceuticals International Inc.; Chugai Pharmaceutical Co. Ltd.; Kyowa Kirin Co. Ltd. Psoriatic Arthritis Treatment Market 2024 Key Insights: • The psoriatic arthritis treatment market size will grow to $17.16 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. • Surging Prevalence Of Psoriasis And Psoriatic Arthritis Drives Growth In Psoriatic Arthritis Treatment Market • Innovative Jak Inhibitors Transform Psoriatic Arthritis Treatment Landscape • North America was the largest region in the psoriatic arthritis treatment market in 2023 We Offer Customized Report, Click @ https://www.thebusinessresearchcompany.com/Customise?id=3458&type=smp Contact Us: The Business Research Company Europe: +44 207 1930 708 Asia: +91 88972 63534 Americas: +1 315 623 0293 Email: info@tbrc.info Follow Us On: LinkedIn: https://in.linkedin.com/company/the-business-research-company Twitter: https://twitter.com/tbrc_info YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ Learn More About The Business Research Company The Business Research Company ( www.thebusinessresearchcompany.com ) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide. This release was published on openPR.